DUBLIN, March 15, 2017 /PRNewswire/ --
The new research portal is an invaluable resource for anyone seeking company research on Novartis and their activities within the pharmaceuticals, eye care and generic drug markets, providing comprehensive research on their market position, competitor activity and their future outlook within these markets.
One such research report available on the portal, Novartis Partnering Deal and Alliance 2010 to 2017, provides an in-depth insight into the partnering activity of one of the world's leading life sciences companies. This includes an infographic visual summary of the company's partnering activity since 2010 according to deal type, industry sector, phase of development, and therapy area.
The portal also features market reports like Global Cardiovascular Disease Market to 2022. The analysts behind this report expect Novartis to become a market leader during the forecasted period. This market will be worth $146.4 billion by 2022.
"The portal provides visitors with unparalleled access to company research on Novartis, enabling them to track the company's performance and impact on the various markets in which it is currently engaged," says Ross Glover, CEO of Research and Markets.
For more information visit http://www.researchandmarkets.com/companies/novartis?cid=zl6s5x
About Research and Markets
Research and Markets is the world's leading market research store.
With more than 1.5 million research resources, we deliver the largest collection of business information products on the market. We offer the most in-depth market analysis across a multitude of industries. Our products provide clients with an unrivalled understanding of their chosen market. No matter how specialist your field, we have the insights and market data to help you make efficient and effective decisions.
Research and Markets
Laura Wood, Senior Manager
For E.S.T. Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets